American Academy of Neurology Annual Meeting

SEATTLE — Davorka Tomic, head of clinical development in neurology at Merck KGaA, spoke with Healio at the 2022 American Academy of Neurology annual meeting about multiple clinical trials for patients with MS.

SEATTLE — COVID-19, caused by SARS-CoV-2 infection, is linked to a wide range of conditions that affect neurological processes, according to an expert at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Trudhesa was effective in treating migraines of varying severity, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Although advancements have been made in immune checkpoint inhibitors, tumors such as glioblastoma present a roadblock to successful therapy, according to a presenter at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Patients with acute ischemic stroke need access to lifesaving thrombectomy in all areas of the world, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Clinicians should consider disease-modifying therapeutics when treating patients with rare pediatric disorders, according to an expert at the 2022 American Academy of Neurology annual meeting.

Patients with Alzheimer’s disease who are treated with lecanemab have shown the potential to reaccumulate brain amyloid after removal of the drug, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE – Inebilizumab was shown to be safe and effective in preventing relapses in individuals with neuromyelitis optica spectrum disorder, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — MRI biomarkers were significantly associated with glial tau pathology and could aid in the diagnosis of certain neurodegenerative diseases, a presenter said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Patients with ALS who were treated with CNM-Au8 — a gold nanocrystal suspension — showed improvements in survival, a speaker said at the 2022 American Academy of Neurology annual meeting.